Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-24-132166

Chief Accounting Officer sold 2,273 shares at $7.43 ($16,888)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Liao Carrie Chief Accounting Officer 2024-12-26 Sale 10b5-1 −2,273 $7.43 $16,888 97,270 D
Open-market sales · 2,273 sh · avg $7.43 · $16,888
Loading xslF345X05/tm2432133-3_4seq1.xml…